Association of the protein tyrosine phosphatase nonreceptor 22 haplotypes with autoimmune thyroid disease in the japanese population

Thyroid

Volumn 20, Issue 8, 2010, Pages 893-899

  Ban, Yoshiyuki ^a   Tozaki, Teruaki ^b   Taniyama, Matsuo ^c   Nakano, Yasuko ^b   Ban, Yoshihisa ^d   Ban, Yoshio ^d   Hirano, Tsutomu ^a  

^a SHOWA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b SHOWA UNIVERSITY   (Japan)

^c SHOWA UNIVERSITY FUJIGAOKA HOSPITAL   (Japan)

^d Ban Thyroid Clinic   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 2 RECEPTOR ALPHA; PROTEIN TYROSINE PHOSPHATASE;

ALLELE; ARTICLE; AUTOIMMUNE THYROIDITIS; CONTROLLED STUDY; GENETIC ASSOCIATION; GENOTYPE; GRAVES DISEASE; HAPLOTYPE; HASHIMOTO DISEASE; HUMAN; JAPANESE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

ALLELES; AUTOIMMUNE DISEASES; DNA MUTATIONAL ANALYSIS; DNA PRIMERS; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HUMANS; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; INTRONS; JAPAN; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 22; THYROID DISEASES;

EID: 77955285797     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.2010.0104     Document Type: Article

References (42)

1. Jacobson DL, Gange SJ, Rose NR, Graham NM 1997 Epidemiology and estimated population burden of selected autoimmune diseases in the United States. Clin Immunol Immunopathol 84:223-243.
2. Hollowell JG, Staehling NW, Flanders WD, Hannon WH, Gunter EW, Spencer CA, Braverman LE 2002 Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab 87:489-499.
3. Davies TF 2000 Graves diseases: pathogenesis. In: Braverman LE, Utiger RD (eds) Werner and Ingbars The Thyroid: A Fundamental and Clinical Text. Lippincott-Raven, Philadelphia, pp 518-530.
4. Weetman AP 1996 Chronic autoimmune thyroiditis. In: Braverman LE, Utiger RD (eds) Werner and Ingbars The Thyroid: A Fundamental and Clinical Text. Lippincott-Raven, Philadelphia, pp 738-748.
5. Tomer Y 1997 Anti-thyroglobulin autoantibodies in autoimmune thyroid diseases: Cross-reactive or pathogenic? Clin Immunol Immunopathol 82:3-11.
6. Tomer Y, Davies TF 2003 Searching for the autoimmune thyroid disease susceptibility genes: from gene mapping to gene function. Endocr Rev 24:694-717.
7. Tomer Y, Davies TF 1993 Infection, thyroid disease and autoimmunity. Endocr Rev 14:107-120.
8. Brix TH, Hansen PS, Kyvik KO, Hegedus L 2000 Cigarette smoking and risk of clinically overt thyroid disease: a population-based twin case-control study. Arch Intern Med 160:661-666.
9. Ban Y, Tomer Y 2003 The contribution of immune regulatory and thyroid specific genes to the etiology of Graves and Hashimotos diseases. Autoimmunity 36:367-379.
10. Jacobson EM, Tomer Y 2007 The CD40, CTLA-4, thyroglobulin, TSH receptor, and PTPN22 gene quintet and its contribution to thyroid autoimmunity: back to the future. J Autoimmun 28:85-98.
11. Mustelin T, Alonso A, Bottini N, Huynh H, Rahmouni S, Nika K, Louis-dit-Sully C, Tautz L, Togo SH, Bruckner S, Mena-Duran AV, al-Khouri AM 2004 Protein tyrosine phosphatases in T cell physiology. Mol Immunol 41:687-700.
12. Bottini N, Musumeci L, Alonso A, Rahmouni S, Nika K, Rostamkhani M, MacMurray J, Meloni GF, Lucarelli P, Pellecchia M, Eisenbarth GS, Comings D, Mustelin T 2004A functional variant of lymphoid tyrosine phosphatase is associated with type 1 diabetes. Nat Genet 36:337-338.
13. Smyth D, Cooper JD, Collins JE, Heward JM, Franklyn JA, Howson JM, Vella A, Nutland S, Rance HE, Maier L, Barratt BJ, Guja C, Ionescu-Tirgoviste C, Savage DA, Dunger DB, Widmer B, Strachan DP, Ring SM, Walker N, Clayton DG, Twells RC, Gough SC, Todd JA 2004 Replication of an association between the lymphoid tyrosine phosphatase locus (LYP/PTPN22) with type 1 diabetes, and evidence for its role as a general autoimmunity locus. Diabetes 53:3020-3023.
14. Ladner MB, Bottini N, Valdes AM, Noble JA 2005 Association of the single nucleotide polymorphism C1858T of the PTPN22 gene with type 1 diabetes. Hum Immunol 66:60-64.
15. Kyogoku C, Langefeld C, Ortmann W, Lee A, Selby S, Carlton VE, Chang M, Ramos P, Baechler EC, Batliwalla FM, Novitzke J, Williams AH, Gillett C, Rodine P, Graham RR, Ardlie KG, Gaffney PM, Moser KL, Petri M, Begovich AB, Gregersen PK, Behrens TW 2004 Genetic association of the R620W polymorphism of protein tyrosine phosphatase PTPN22 with human SLE. Am J Hum Genet 75:504-507.
16. Criswell LA, Pfeiffer KA, Lum RF, Gonzales B, Novitzke J, Kern M, Moser KL, Begovich AB, Carlton VE, Li W, Lee AT, Ortmann W, Behrens TW, Gregersen PK 2005 Analysis of families in the multiple autoimmune disease genetics consortium (MADGC) collection: the PTPN22 620W allele associates with multiple autoimmune phenotypes. Am J Hum Genet 76:561-571.
17. Velaga MR, Wilson V, Jennings CE, Owen CJ, Herington S, Donaldson PT, Ball SG, James RA, Quinton R, Perros P, Pearce SH 2004 The codon 620 tryptophan allele of the lymphoid tyrosine phosphatase (LYP) gene is a major determinant of Graves disease. J Clin Endocrinol Metab 89:5862-5865.
18. Skórka A, Bednarczuk T, Bar-Andziak E, Nauman J, Ploski R 2005 Lymphoid tyrosine phosphatase (PTPN22/LYP) variant and Graves disease in a Polish population: association and gene dose-dependent correlation with age of onset. Clin Endocrinol (Oxf ) 62:679-682.
19. Begovich A, Carlton V, Honigberg L, Schrodi SJ, Chokkalingam AP, Alexander HC, Ardlie KG, Huang Q, Smith AM, Spoerke JM, Conn MT, Chang M, Chang SY, Saiki RK, Catanese JJ, Leong DU, Garcia VE, McAllister LB, Jeffery DA, Lee AT, Batliwalla F, Remmers E, Criswell LA, Seldin MF, Kastner DL, Amos CI, Sninsky JJ, Gregersen PK 2004A missense single-nucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis. Am J Hum Genet 75:330-337.
20. Lee AT, Li W, Liew A, Bombardier C, Weisman M, Massarotti EM, Kent J, Wolfe F, Begovich AB, Gregersen PK 2005 The PTPN22 R620W polymorphism associates with RF positive rheumatoid arthritis in a dose-dependent manner but not with HLA-SE status. Genes Immun 6:129-133.
21. Viken MK, Amundsen SS, Kvien TK, Boberg KM, Gilboe IM, Lilleby V, Sollid LM, Førre, OT, Thorsby E, Smerdel A, Lie BA 2005 Association analysis of the 1858C>T polymorphism in the PTPN22 gene in juvenile idiopathic arthritis and other autoimmune diseases. Genes Immun 6:271-273.
22. Cantón I, Akhtar S, Gavalas NG, Gawkrodger DJ, Blomhoff A, Watson PF, Weetman AP, Kemp EH 2005 A singlenucleotide polymorphism in the gene encoding lymphoid protein tyrosine phosphatase (PTPN22) confers susceptibility to generalised vitiligo. Genes Immun 6:584-587.
23. Ban Y, Tozaki T, Taniyama M, Tomita M, Ban Y 2005 The codon 620 single nucleotide polymorphism of the protein tyrosine phosphatase-22 gene does not contribute to autoimmune thyroid disease susceptibility in the Japanese. Thyroid 15:1115-1118.
24. Ikari K, Momohara S, Inoue E, Tomatsu T, Hara M, Yamanaka H, Kamatani N 2006 Haplotype analysis revealed no association between the PTPN22 gene and RA in a Japanese population. Rheumatology 45:1345-1348.
25. Kawasaki E, Awata T, Ikegami H, Kobayashi T, Maruyama T, Nakanishi K, Shimada A, Uga M, Kurihara S, Kawabata Y, Tanaka S, Kanazawa Y, Lee I, Eguchi K 2006 Systematic search for single nucleotide polymorphisms in a lymphoid tyrosine phosphatase gene (PTPN22): association between a promoter polymorphism and type 1 diabetes in Asian populations. Am J Med Genet A 140:586-593.
26. Cinek O, Hradsky O, Ahmedov G, Slavcev A, Kolouskova S, Kulich M, Sumnik Z 2007 No independent role of the-1123 G>C and 2740 A>G variants in the association of PTPN22 with type 1 diabetes and juvenile idiopathic arthritis in two Caucasian populations. Diabetes Res Clin Pract 76:297-303.
27. Viken MK, Olsson M, Flåm ST, Førre O, Kvien TK, Thorsby E, Lie BA 2007 The PTPN22 promoter polymorphism-1123G>C association cannot be distinguished from the 1858C>T association in a Norwegian rheumatoid arthritis material. Tissue Antigens 70:190-197.
28. Carlton VE, Hu X, Chokkalingam AP, Schrodi SJ, Brandon R, Alexander HC, Chang M, Catanese JJ, Leong DU, Ardlie KG, Kastner DL, Seldin MF, Criswell LA, Gregersen PK, Beasley E, Thomson G, Amos CI, BegovichAB 2005 PTPN22 genetic variation: evidence for multiple variants associated with rheumatoid arthritis. Am J Hum Genet 77:567-581.
29. Kim HP, Imbert J, Leonard WJ 2006 Both integrated and differential regulation of components of the IL-2/IL-2 receptor system. Cytokine Growth Factor Rev 17:349-366.
30. Vella A, Cooper JD, Lowe CE, Walker N, Nutland S, Widmer B, Jones R, Ring SM, McArdle W, Pembrey ME, Strachan DP, Dunger DB, Twells RC, Clayton DG, Todd JA 2005 Localization of a type 1 diabetes locus in the IL2RA/CD25 region by use of tag single-nucleotide polymorphisms. Am J Hum Genet 76:773-779.
31. Brand OJ, Lowe CE, Heward JM, Franklyn JA, Cooper JD, Todd JA, Gough SC 2007 Association of the interleukin-2 receptor a (IL-2Ra)/CD25 gene region with Graves disease using a multilocus test and tag SNPs. Clin Endocrinol (Oxf ) 66:508-512.
32. Wellcome Trust Case Control Consortium 2007 Genomewide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 447:661-678.
33. Hafler DA, Compston A, Sawcer S, Lander ES, Daly MJ, De Jager PL, de Bakker PI, Gabriel SB, Mirel DB, Ivinson AJ, Pericak-Vance MA, Gregory SG, Rioux JD, McCauley JL, Haines JL, Barcellos LF, Cree B, Oksenberg JR, Hauser SL 2007 Risk alleles for multiple sclerosis identified by a genomewide study. N Engl J Med 357:851-862.
34. Kawasaki E, Awata T, Ikegami H, Kobayashi T, Maruyama T, Nakanishi K, Shimada A, Uga M, Kurihara S, Kawabata Y, Tanaka S, Kanazawa Y, Eguchi K; Japanese Study Group on Type 1 Diabetes Genetics 2009 Genetic association between the interleukin-2 receptor-alpha gene and mode of onset of type 1 diabetes in the Japanese population. J Clin Endocrinol Metab 94:947-952.
35. Dynacom SNPAlyze program. 2010. www.dynacom.co.jp/ e/products/package/ snpalyze/.
36. Cohen S, Dadi H, Shaoul E, Sharfe N, Roifman CM 1999 Cloning and characterization of a lymphoid-specific, inducible human protein tyrosine phosphatase, Lyp. Blood 93:2013-2024.
37. Cloutier JF, Veillette A 1999 Cooperative inhibition of T-cell antigen receptor signaling by a complex between a kinase and a phosphatase. J Exp Med 189:111-121.
38. Hill RJ, Zozulya S, Lu YL, Ward K, Gishizky M, Jallal B 2002 The lymphoid protein tyrosine phosphatase Lyp interacts with the adaptor molecule Grb2 and functions as a negative regulator of T-cell activation. Exp Hematol 30:237-244.
39. Lee YH, Rho YH, Choi SJ, Ji JD, Song GG, Nath SK, Harley JB 2007 The PTPN22 C1858T functional polymorphism and autoimmune diseases: a meta-analysis. Rheumatology (Oxf ) 46:49-56.
40. Ichimura M, Kaku H, Fukutani T, Koga H, Mukai T, Miyake I, Yamada K, Koda Y, Hiromatsu Y 2008 Associations of protein tyrosine phosphatase nonreceptor 22 (PTPN22) gene polymorphisms with susceptibility to Graves disease in a Japanese population. Thyroid 18:625-630.
41. Orrú V, Tsai SJ, Rueda B, Fiorillo E, Stanford SM, Dasgupta J, Hartiala J, Zhao L, Ortego-Centeno N, DAlfonso S; Italian Collaborative Group, Arnett FC, Wu H, Gonzalez-Gay MA, Tsao BP, Pons-Estel B, Alarcon-Riquelme ME, He Y, Zhang ZY, Allayee H, Chen XS, Martin J, Bottini N 2009 A loss-offunction variant of PTPN22 is associated with reduced risk of systemic lupus erythematosus. Hum Mol Genet 18:569-579.
42. Onengut-Gumuscu S, Buckner JH, Concannon P 2006 A haplotype-based analysis of the PTPN22 locus in type 1 diabetes. Diabetes 55:2883-2889.